Saturday | 30 August, 2008
Stories about: Bionomics
- +
Pharma and academia - how opposites attract 07/08/2008 11:49:09
They may have sneered at each other in the past, but collaborative efforts for translational research between academia and industry are happening, and they are working. - +
Biotech summit approaches 23/07/2008 12:24:56
The annual Australian Biotechnology Summit begins next week - +
First steps for Bionomics' anti-anxiety drug 09/07/2008 16:37:40
Bionomics completes GMP synthesis of anxiety drug candidate - +
Big deal for Bionomics 20/06/2008 05:19:07
Bionomics to license compounds to Merck Serono for MS treatment development - +
This week in Oz biotech 18/04/2008 13:33:34
Eastland's under the tongue, Bionomics disrupts further, Novogen adds on and Mesoblast's arthritic sheep. - +
Big week for Australian biotechs 12/03/2008 15:49:21
Progen goes into Phase III and ChemGenex Phase II, Bionomics looks at anxiety, Clinuvel gets orphan designation and Avexa announces collaboration and good results. - +
Bionomics begins Phase 1 trial 27/02/2008 11:46:24
The first patients have begun treatment in Bionomics' Phase 1 trial of its vascular disruption agent. - +
BIO profile: Hit and hit again for Bionomics 18/04/2007 11:01:21
Bionomics has some good news to take to BIO 2007 from preclinical trials of its candidate vascular disruption agent. - +
Australia at BIO 2007 03/04/2007 12:11:49
The special BIO 2007 issue of Australian Life Scientist is out now. - +
Genmab licenses Bionomics angiogenesis targets 14/02/2006 12:05:48
Danish biotech Genmab has acquired exclusive worldwide rights to angiogenesis targets identified by Adelaide-based Bionomics (ASX:BNO). - +
Bionomics licenses two epilepsy diagnostics to LabCorp 03/11/2005 14:24:09
Bionomics (ASX:BNO) has licensed two genetic tests for the diagnosis of epilepsy to US giant Laboratory Corporation of America.
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
Beyond The Hybrid TV Card Norm 2008-08-26 15:29:00+10
Go Green with Kingston - Save the PCB, Save the World 2008-08-25 16:10:00+10
VIA Pico-ITX at the Heart of Modern Robots 2008-08-25 13:50:00+10
Fujitsu unveils winning formula for success with Intel® Centrino® 2 processor technology. 2008-08-25 12:42:00+10
Multimedia Technology & Herma Technologies announce new audience feedback solution from REPLY Systems. 2008-08-19 11:05:00+10
Sponsored Links
Subscribe to Australian Life Scientist
Australian Life Scientist is Australia's leading magazine for the life sciences sector. ALS is available free of charge to qualified persons working in the life sciences - register now for your free subscription.
